SCHEMBL6136228

SCHEMBL6136228

CCOC(=O)CCNCc1ccc(OC)c(OC)c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.58
HDAC1 Q13547 2/20 0.58
HDAC2 Q92769 2/20 0.58
HDAC8 Q9BY41 2/20 0.58
KDM4E B2RXH2 2/20 0.58
POLB P06746 1/20 0.58
ALDH1A1 P00352 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
EPHX2 P34913 1/20 0.51
CA12 O43570 3/20 0.50
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA9 Q16790 3/20 0.50
CA4 P22748 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6136380 0.94 L3MBTL1 (0.61) HDAC3HDAC1HDAC2HDAC8KDM4E
SCHEMBL6136381 0.87 BCHE (0.64) KDM4EALDH1A1SMN1; SMN2KMT2A
SCHEMBL6136444 0.86 LMNA (0.54) KDM4EPOLBALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL4655867 0.86 ALDH1A1 (0.57) HDAC3HDAC1HDAC2HDAC8KDM4E
SCHEMBL9832305 0.85 ALDH1A1 (0.56) KDM4EALDH1A1MEN1KMT2A
SCHEMBL3187109 0.83 KDM4E (0.64) HDAC3HDAC1HDAC2HDAC8KDM4E
SCHEMBL9832496 0.82 KDM4E (0.58) HDAC3HDAC1HDAC2HDAC8KDM4E
SCHEMBL491276 0.81 CYP4F2 (0.59) KDM4ESMN1; SMN2CA12CA1CA2
SCHEMBL11322410 0.81 SLC2A1 (0.53) POLBCA12CA1CA2CA9
SCHEMBL9830258 0.80 MEN1 (0.61) HDAC3HDAC1HDAC2HDAC8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0449989-A1 6,7 DIHYDROPYRROLO 3,4-c] PYRIDO 2,3-d] PYRIMIDINE DERIVATIVES Sloan-Kettering Institute For Cancer Research (US) 1991-10-09 EP claimed
WO-1990007496-A1 6,7 DIHYDROPYRROLO[3,4-c] PYRIDO[2,3-d] PYRIMIDINE DERIVATIVES SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-07-12 WO claimed
EP-1042279-B1 SUBSTITUTED BETA-ALANINES AVENTIS PHARMA LTD (GB) 2005-03-02 EP disclosed
CN-1163477-C Substituted beta-alanines 2004-08-25 CN disclosed
US-6352977-B1 ALANINE WITH PRODRUGS AVENTIS PHARMA LIMITED (GB) 2002-03-05 US disclosed
CN-1283181-A Substituted beta-alanines AWONGTISFAMA CO LTD (GB) 2001-02-07 CN disclosed
EP-1042279-A1 SUBSTITUTED BETA-ALANINES Aventis Pharma Limited (GB) 2000-10-11 EP disclosed
WO-1999033789-A1 SUBSTITUTED β-ALANINES AVENTIS PHARMA LIMITED (GB) 1999-07-08 WO disclosed
EP-0449989-A1 6,7 DIHYDROPYRROLO 3,4-c] PYRIDO 2,3-d] PYRIMIDINE DERIVATIVES Sloan-Kettering Institute For Cancer Research (US) 1991-10-09 EP disclosed
WO-1990007496-A1 6,7 DIHYDROPYRROLO[3,4-c] PYRIDO[2,3-d] PYRIMIDINE DERIVATIVES SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-07-12 WO disclosed
US-4925939-A 6,7-dihydropyrrol[3,4-c]pyrido[2,3-d]pyrimidine derivatives SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-05-15 US disclosed